Wang, Jeffrey B. http://orcid.org/0000-0002-8933-9822
Hassan, Umair
Bruss, Joel E.
Oya, Hiroyuki http://orcid.org/0000-0002-1733-5478
Uitermarkt, Brandt D.
Trapp, Nicholas T.
Gander, Phillip E. http://orcid.org/0000-0003-3945-8820
Howard, Matthew A. III
Keller, Corey J. http://orcid.org/0000-0003-0529-3490
Boes, Aaron D. http://orcid.org/0000-0002-7865-9257
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (1R01 MH132074, R21MH120441, F30MH119763, 5T32-MH019113, R01MH129018)
Roy J. Carver Charitable Trust
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (4 R01NS114405)
Mark and Mary Stevens Interdisciplinary Graduate Fellowship
Burroughs Wellcome Fund
Article History
Received: 6 December 2022
Revised: 19 December 2023
Accepted: 2 January 2024
First Online: 5 February 2024
Competing interests
: CJK currently holds equity in Alto Neurosciences, Inc. The other authors declare no competing interests.